Liver transplantation across ABO blood groups in children.
Late results after ABOI LTx are inferior to ABO compatible organs. We report seven patients who received LTx across ABO group for emergency indications. The blood type combinations were: A to O in three, B to O in two, and B to A in two. Episodes of acute and chronic rejection, immunosuppression, and biochemical and functional tests after transplantation as well as patient and graft survival were compared between ABOI group and patients with compatible ABO group transplanted due to FLF (group I) or in an elective setting (group II). Four children are alive. Two children died of sepsis and CNS damage or MOF, and one patient died during transplantation because of cardiac failure. All recipients of ABOI grafts received immunosuppression with cyclosporine or tacrolimus and steroids. MMF was added in two subjects, and induction with antilymphocyte globulins used in five patients. An acute rejection episode was diagnosed in two recipients between 7 and 11 days after LTx. All four living patients with ABOI grafts are doing well with follow-up time between 11 months and 5 years. In one patient PTLD occurred at 1 year after ABOI LTx but was cured by discontinuation of immunosuppression and administration of rituximab. Graft survival in the ABOI group was 57.1% versus 71% in group I and 73% in group II. Respective patients survival was 57.1% 71%, and 82.0% respectively. In conclusion, in urgent cases ABOI transplantation is justified in pediatric patients when compatible grafts are not available.
Szymczak
M
M
Department of Pediatric Surgery and Organ Transplantation, Warsaw, Poland.
Kalicinski
P
P
Kaminski
A
A
Ismail
H
H
Drewniak
T
T
Nachulewicz
P
P
Broniszczak
D
D
D000017:ABO Blood-Group System / Q000276:immunology*; D002648:Child; D006501:Hepatic Encephalopathy / Q000601:surgery; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D012189:Retrospective Studies; D016019:Survival Analysis
D000017:ABO Blood-Group System